Expertise in
2
conditions

Thomas R. Rimmele

Faculté De Médecine Lyon Est, 
Lyon, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
2
conditions
Faculté De Médecine Lyon Est, 
Lyon, FR 
OverviewLocationsClinical Research

Overview

Thomas Rimmele practices in Lyon, France. Mr. Rimmele is highly rated in 2 conditions, according to our data. His top areas of expertise are Sepsis, Metabolic Acidosis, COVID-19, Kidney Transplant, and Pancreas Transplant.

His clinical research consists of co-authoring 220 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Faculté De Médecine Lyon Est, Lyon, 69008, France
Other Locations
3550 Terrace St, Pittsburgh, PA 15213

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration
Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration
Enrollment Status: Recruiting
Publish Date: June 12, 2024
Intervention Type: Biological
Assessment of Therapeutic Plasma Exchange to Improve Respiratory Function by Alleviating Cytokine Storm During Severe Covid-19 Infections Randomised Open-label Controlled Trial
Assessment of Therapeutic Plasma Exchange to Improve Respiratory Function by Alleviating Cytokine Storm During Severe Covid-19 Infections Randomised Open-label Controlled Trial
Enrollment Status: Completed
Publish Date: September 03, 2025
Intervention Type: Other
Study Phase: Not Applicable
A Double-Blind, Randomized, Placebo-controlled Multicenter Trial of GRanulocyte-Macrophage Colony-stimulating Factor Administration to Decrease ICU Acquired Infections in Sepsis-induced ImmunoDepression
A Double-Blind, Randomized, Placebo-controlled Multicenter Trial of GRanulocyte-Macrophage Colony-stimulating Factor Administration to Decrease ICU Acquired Infections in Sepsis-induced ImmunoDepression
Enrollment Status: Completed
Publish Date: September 03, 2025
Intervention Type: Drug
Study Phase: Phase 3
Endotoxins and Cytokines Removal During Continuous Hemofiltration With oXiris™
Endotoxins and Cytokines Removal During Continuous Hemofiltration With oXiris™
Enrollment Status: Completed
Publish Date: December 05, 2023
Intervention Type: Biological, Device
Study Phase: Not Applicable
Validation of the Efficiency of Molecules Reproposed on the Basis of Their Cellular Transcriptomic Signature, Antagonist of the Signature Determined in Infection Due to Virus Influenza A.
Validation of the Efficiency of Molecules Reproposed on the Basis of Their Cellular Transcriptomic Signature, Antagonist of the Signature Determined in Infection Due to Virus Influenza A.
Enrollment Status: Terminated
Publish Date: February 06, 2023
Intervention Type: Drug
Study Phase: Phase 2
The OPTI-AGED Study : Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality in Elderly Patients. A Randomized, Multicentre, Prospective Controlled Study
The OPTI-AGED Study : Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality in Elderly Patients. A Randomized, Multicentre, Prospective Controlled Study
Enrollment Status: Completed
Publish Date: August 26, 2021
Intervention Type: Procedure
Study Phase: Not Applicable
Assessment of Postoperative Lymphopenia as Risk Factor for Postoperative Infections: EVALYMPH Study
Assessment of Postoperative Lymphopenia as Risk Factor for Postoperative Infections: EVALYMPH Study
Enrollment Status: Completed
Publish Date: January 20, 2021
Intervention Type: Other
Prevalence Study : Elderly Patients and Rehabilitation in ICU. Impact of Frailty.
Prevalence Study : Elderly Patients and Rehabilitation in ICU. Impact of Frailty.
Enrollment Status: Completed
Publish Date: August 14, 2019
Intervention Type: Other
REAnimation Low Immune Status Markers
REAnimation Low Immune Status Markers
Enrollment Status: Completed
Publish Date: September 17, 2018
Intervention Type: Biological
Study Phase: Not Applicable
Creation of Arteriovenous Ante-brachial Fistula Under Axillary Block Versus Local Anesthesia : Impact on Early Complications
Creation of Arteriovenous Ante-brachial Fistula Under Axillary Block Versus Local Anesthesia : Impact on Early Complications
Enrollment Status: Completed
Publish Date: August 28, 2018
Intervention Type: Drug
Study Phase: Not Applicable
Safety Profile of IntRAvenous Lidocaine Use in Coelioscopic Bariatric Surgery
Safety Profile of IntRAvenous Lidocaine Use in Coelioscopic Bariatric Surgery
Enrollment Status: Completed
Publish Date: August 03, 2017
Intervention Type: Biological, Drug
Study Phase: Phase 3
View 10 Less Clinical Trials

219 Total Publications

Publisher Correction: Monocyte HLA-DR expression in septic shock patients: insights from a 20-year real-world cohort of 1023 cases.
Publisher Correction: Monocyte HLA-DR expression in septic shock patients: insights from a 20-year real-world cohort of 1023 cases.
Journal: Intensive care medicine
Published: October 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Rimmele's expertise for a condition
ConditionClose
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile